Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
about
Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactionsInsights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the USLeucoreduction of blood components: an effective way to increase blood safety?A high-throughput microfluidic approach for 1000-fold leukocyte reduction of platelet-rich plasmaClinical effects of reverting from leukoreduced to nonleukoreduced blood in cardiac surgery.Approach of using established and new laboratory tests to more comprehensively investigate noninfectious and nonhemolytic transfusion reactions--along with the experience in Japan.Cost-effectiveness of leucoreduction for prevention of febrile non-haemolytic transfusion reactionsRole of Leukoreduction of Packed Red Blood Cell Units in Trauma Patients: A ReviewLeukoreduced blood components: Advantages and strategies for its implementation in developing countries.The platelet as an immune cell-CD40 ligand and transfusion immunomodulationRecognition, Investigation and Management of Acute Transfusion Reactions: Consensus guidelines for Oman.An association between decreased cardiopulmonary complications (transfusion-related acute lung injury and transfusion-associated circulatory overload) and implementation of universal leukoreduction of blood transfusions.Inactivation of human white blood cells in platelet products after pathogen reduction technology treatment in comparison to gamma irradiation.Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?Study of acute transfusion reactions in a teaching hospital of Sikkim: A hemovigilance initiative.Leukocyte antigen and antibody detection assays: tools for assessing and preventing pulmonary transfusion reactionsPremedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.Frequency and pattern of noninfectious adverse transfusion reactions at a tertiary care hospital in KoreaTransfusion premedications: a growing practice not based on evidence.Red Blood Cell Transfusions Impact Pneumonia Rates After Coronary Artery Bypass Grafting.Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.Scratching the surface of allergic transfusion reactions.The prevention of adverse reactions to transfusions in patients with haemoglobinopathies: a proposed algorithm.Transfusion of stored autologous blood does not alter reactive hyperemia index in healthy volunteers.Clinical relevance of the HLA system in blood transfusion.Effects of Leukoreduction and Premedication With Acetaminophen and Diphenhydramine in Minimizing Febrile Nonhemolytic Transfusion Reactions and Allergic Transfusion Reactions During and After Blood Product Administration: A Literature Review With ReEffects of Prestorage Leukoreduction on the Rate of Febrile Nonhemolytic Transfusion Reactions to Red Blood Cells in a Tertiary Care Hospital.Incidence of hypotension and acute hypotensive transfusion reactions following platelet concentrate transfusions.Aging of platelets stored for transfusion.Is intensive monitoring during the first transfusion in pediatric patients necessary?The effects of red cell transfusion donor age on nosocomial infection among trauma patients.Febrile non-haemolytic transfusion reaction occurrence and potential risk factors among the U.S. elderly transfused in the inpatient setting, as recorded in Medicare databases during 2011-2012.Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries.Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets.Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions.A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history.Evaluation of White Blood Cell- and Platelet-Derived Cytokine Accumulation in MIRASOL-PRT-Treated Platelets.Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.
P2860
Q24234953-6041DEBA-1F22-4E43-AE9C-188A1C1BB2ADQ24288772-88EADC36-42CD-43D5-A854-2AAAB54F17C3Q26771857-D1170BA7-8573-4190-BD08-18F54986216DQ30826060-04417BCD-292D-4513-8C44-6F42923CD003Q33236246-5F28A018-0E0E-42FB-A752-477D697F26D5Q33408363-0B1F8679-2357-4ED3-B59E-891CF327BC53Q33690883-A4730284-26EC-4DBD-93EF-1620F73CC50DQ33707808-66EB8B18-866D-4179-A5DD-7DD1505DEA92Q33760699-7AB135DD-94EC-47E0-8803-70BB38A1CE51Q33937074-333A5F24-940C-43AE-AD9D-90D21019F7DAQ33982899-9231B847-A772-45E2-B6E4-2FD183D9A529Q34148215-E8E59ADD-27BD-4432-A434-A34986088FF5Q34154813-4E50DE0C-5039-4A9C-8587-764E297BF7A0Q34423678-77D46CDE-5C47-4B76-B3D1-F498238ADFD2Q35109407-6A3559E8-35BC-49EC-B8A3-E7DADC181087Q35792449-24C6D2D7-8CBB-4B59-B7C5-7E9FE0F9655FQ35922810-980B6076-EEE3-445D-8A91-22BF124A8BF5Q36092285-5A8ED549-699F-4009-8D27-EB5BE20984B5Q36237664-B387CA94-E391-4B9F-BEBD-C71D9339A580Q36419679-880FA794-FCB4-4254-9E9D-C0B1F1605EDCQ36831189-FB731A97-F2C5-47D6-B25F-BDF785B413FEQ36996206-C16AB645-6257-415D-B49C-D24993569A84Q37012096-94CE7CBE-783B-41D9-AA6D-42A59753D504Q37012102-6E13DCC3-D2E0-4D96-AEC1-F62978ED25D2Q37059214-D0F594C6-847D-4FD7-B918-632E0EA01C7DQ37693437-A9255A6D-14A0-4E76-A05B-65D3ED5EEBCEQ37871065-6C6B7B7E-8E3E-46B2-AF9D-FD136A67B353Q38209256-D803F0C7-585E-4934-946E-A476FF9301B9Q38534070-D4695AE6-D960-4AB1-85ED-B7F8EEFCA0F6Q38590241-ECE6DD57-B0E8-4649-AF8F-14AB5D91B208Q38822804-BAD60B2A-BE45-4E02-94D4-B31073E8A0B7Q39343047-9AA5C133-1EB4-4E26-A3EF-588F65D0F09FQ40129640-96B7D214-08E7-456C-9208-17335B270D6EQ40179540-802FD2A6-D513-41F9-B42B-4586E1484714Q40186836-894DD6ED-4793-4AA5-9F29-E467E033246CQ40277127-6365FF52-D2BB-4B3F-B445-E6E4695D293DQ40815665-F1877B27-24C9-4313-BD15-9142522E9CC1Q41655074-9953C087-DD32-4F68-A945-BA6D281FA99BQ41789969-4E72AFCD-637F-4215-AF16-4812667B35F6Q43092210-350BE608-7E19-46FB-9D58-74AC51D84C0B
P2860
Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Reduction of febrile but not a ...... sal prestorage leukoreduction.
@en
type
label
Reduction of febrile but not a ...... sal prestorage leukoreduction.
@en
prefLabel
Reduction of febrile but not a ...... sal prestorage leukoreduction.
@en
P2093
P2860
P1433
P1476
Reduction of febrile but not a ...... sal prestorage leukoreduction.
@en
P2093
Edward L Snyder
Gene S Fisch
Gregory J Pomper
Justin C Paglino
Melanie H Champion
P2860
P356
10.1046/J.0041-1132.2004.00608.X
P577
2004-01-01T00:00:00Z